ArticleNature nanotechnology2026
Nanopore-enabled time-resolved monitoring of catecholamine-related phenylalanine metabolism.
Article in Nature nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
Catecholamines, including dopamine, noradrenaline (also known as norepinephrine) and adrenaline (also known as epinephrine), are essential regulators of neural and endocrine function. Although they are synthesized through a branched phenylalanine metabolic pathway, direct and dynamic monitoring of the enzymatic processes governing their production has remained challenging. Here we reconstitute the complete catecholamine biosynthetic pathway from phenylalanine to adrenaline in vitro using purified enzymes and cofactors, and couple this system with nanopore-based single-molecule sensing. By integrating two orthogonal molecular recognition modalities within a single nanopore platform, we achieve highly specific detection of all metabolic intermediates and end products throughout the pathway. Real-time monitoring enables direct observation of pathway progression and regulatory perturbations at single-molecule resolution. Using this approach, we show that 6-methylisothiocyanate disrupts catecholamine biosynthesis, providing mechanistic insight into how iodotyrosine dehalogenase 1 (DEHAL1) deficiency may compromise catecholamine production. Together, this integrated enzymology and label-free nanopore sensing platform enables time-resolved dissection of neurotransmitter metabolism and regulation, and offers a general framework for studying complex biochemical pathways with single-molecule resolution.
Identifiers
42680921What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.